Sep 30, 2021

Revolution Medicines Q3 2021 Earnings Report

Total Revenue
$1.1M
Previous year: $12.7M
-91.3%
EPS
-$0.72
Previous year: -$0.42
+71.4%
Gross Profit
-$45.4M
Cash and Equivalents
$129M
Free Cash Flow
-$37M
Total Assets
$735M

Revolution Medicines

Revolution Medicines